For research use only. Not for therapeutic Use.
BCL6-IN-7 is a potent BCL6−corepressor interaction inhibitor[1].
Catalog Number | I023061 |
CAS Number | 2097518-46-0 |
Synonyms | 5-[[5-chloro-2-(pyridin-3-ylmethylamino)pyrimidin-4-yl]amino]-1,3-dihydroindol-2-one |
Molecular Formula | C18H15ClN6O |
Purity | ≥95% |
InChI | InChI=1S/C18H15ClN6O/c19-14-10-22-18(21-9-11-2-1-5-20-8-11)25-17(14)23-13-3-4-15-12(6-13)7-16(26)24-15/h1-6,8,10H,7,9H2,(H,24,26)(H2,21,22,23,25) |
InChIKey | MUSYPBPUEKXCSS-UHFFFAOYSA-N |
SMILES | C1C2=C(C=CC(=C2)NC3=NC(=NC=C3Cl)NCC4=CN=CC=C4)NC1=O |
Reference | [1]. Kamada Y, et al. Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach. J Med Chem. 2017 May 25;60(10):4358-4368. |